chartexchange

Vertex, ahead of FDA decision, calms fears surrounding kidney drug

BioPharma Dive | Nov 3, 2026 12:32 PM EST

On a conference call, executives expressed conviction in the coming launch of an IgA nephropathy medicine viewed by Wall Street investors as important to Vertex’s future. 

Read original article